SUSTAINABILITY MEETING
Aiming to Enhance the Sustainability of Society and Astellas' Corporate Value
Kenji Yasukawa, Ph.D.
President and CEO
Astellas Pharma Inc.
February 28, 2022
CAUTIONARY STATEMENT REGARDING FORWARD- | |
2 | |
LOOKING INFORMATION | |
In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma. These statements are based on management's current assumptions and beliefs in light of the information currently available to it and involve known and unknown risks and uncertainties. A number of factors could cause actual results to differ materially from those discussed in the forward-looking statements. Such factors include, but are not limited to: (i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue to effectively research and develop products accepted by customers in highly competitive markets, and (vi) infringements of Astellas' intellectual property rights by third parties.
Information about pharmaceutical products (including products currently in development) which is included in this material is not intended to constitute an advertisement or medical advice.
VISION | 3 |
-On the forefront of healthcare change to turn innovative science into VALUE for patients- | |
Astellas' | VISION | |
sustainable growth | Corporate | |
Strategic | ||
Strategic Goals | Plan | |
2021 | ||
1 | 2 | 3 |
Enable patients to | Translate | Advance the Rx+ |
achieve better | innovative science | |
business | ||
outcomes | into proven VALUE | |
4
Deepen our engagement in sustainability
Organizational Health Goals
Sustainability* of Society
Human capital
Social and
relationship
capital
Natural capital
- Promoting Innovation
- Talent & Leadership thrives
- Penetration of collaboration
Fostering a corporate culture that aims to achieve ambitious goals
Significantly improving Astellas' implementation capabilities
Intellectual
capital
*IIRC: Integrated Reporting Framework
AGENDA | 4 |
I | Improving Access to Health | IV |
II | Climate Change Measures | V |
III | Corporate Governance | VI |
People and Organizational Development
Materiality Matrix
Items That We Perceive to Be Expected by The Stock Market
IMPROVING ACCESS TO HEALTH
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Astellas Pharma Inc. published this content on 28 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 February 2022 03:11:03 UTC.